Care & Safety
FDA Adds Vision Loss Warning to All GLP-1 Drugs: What to Know
The FDA now requires a warning on all GLP-1 drugs about NAION, a rare cause of vision loss. Here is what its review found.
U.S.-based company. Licensed U.S. clinicians. U.S.-licensed pharmacy partners. U.S.-based support.
Medication quality, legitimate care, gray-market education, and regulatory news.
Care & Safety
The FDA now requires a warning on all GLP-1 drugs about NAION, a rare cause of vision loss. Here is what its review found.
Care & Safety
A vial shows up in the mail. The label says: “Research Use Only.” Maybe the website also says: “Not for Human Consumption.” Then, two inches farther down the…
Care & Safety
One of the most common questions about GLP-1 weight-management medications is also one of the most important: What happens when you stop? It is easy to focus on…